Aegle marmelos (A. marmelos) appears to be a significantly used ayurvedic medicine.
This is a brilliantly composed nutritious fruit with carbohydrates, proteins, vitamins like riboflavin,
thiamine, niacin, fatty acids, and minerals. Scientific studies have proved that A. marmelos has
phytochemicals: carotenoids, phenolic, alkaloids, pectins, tannins, coumarins, flavonoids and terpenoids. Recent research on the effects of A. marmelos proved its anticancer, antimicrobial, cardioprotective, antidiabetic, and hepatoprotective activities. Extracts of various parts of plants such as
leaves, bark, stems, fruits, and pulp subjected to preclinical studies conducted on cell lines showed
apoptosis induction, inhibition of cell cycle and inhibition of proliferation of cells. Anti-cancer activity of A. marmelos was studied on selected cell lines of lung cancer, breast cancer, colon cancer
and leukaemia. A. marmelos reported significant inhibitory effect on cell proliferation in cell line
studies on A549, Ehrlich Ascites Carcinoma, MNU, DMBA, MCF-7, k562 cells, t-lymphoid Jurkat
cells, b lymphoid Raji cells, erythroleukemic Hel cells, melanoma Colo 38 cells which supports the
anticancer potential of it. Imperatorin has shown an antiproliferative effect on several cancer cell
lines. The hydroethanolic extract of A. marmelos leaves showed a decrease in cell viability on A549
Human lung cancer cell line which works by fold change over control of the β-Catenin-m RNA and
Wnt-mRNA expression of A549 and tumour growth suppression in DMBA induced carcinogenesis
in rats. In human promyelocytic leukaemia, HL-60 cells, imperatorin from A. marmelos has caused
cytochrome c-dependent apoptosis. Drugs interfere with the proliferative and survival signals that
suppress the growth of K562 cells by blocking BCR-ABL1. Proper awareness, development of
formulation and consumption of it make this drug scale up commercially.